Usv Plans Divestment To Raise Rs 200 Cr For Biotech Project

USV Ltd, a Rs 360 crore pharma firm, is exploring the possibilities of raising funds either through a strategic divestment or public float for its expansion plans involving an investment of Rs 200 crore.

USV was incorporated in 1961 as a joint venture with US Vitamins and Pharmaceutical Corporation of the US, a subsidiary of Revlon. At present, USV is fully owned by Indian promoters.